Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
05/30/2003 | WO2003043517A2 Dentifrice compositions |
05/30/2003 | WO2003043486A2 Matrix for the production of tissue engineered ligaments, tendons and other tissue |
05/30/2003 | WO2003043418A1 Anti-pathogenic composition useful in blood preservation |
05/30/2003 | WO2003027281A3 Pluripotent stem cells originating in skeletal muscle intestinal tissue |
05/30/2003 | WO2003020104A3 Method of treating systemic inflammatory response syndrome |
05/30/2003 | WO2003014337A3 Fusion of cells |
05/30/2003 | WO2003008007A3 Device for regeneration of articular cartilage and other tissue |
05/30/2003 | WO2002089675A3 Wound closure system and methods |
05/30/2003 | WO2002077029A3 Cd19-specific redirected immune cells |
05/30/2003 | WO2002067856A3 Injection molding of living tissues |
05/30/2003 | WO2002066040A3 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
05/30/2003 | WO2001080760A8 Method for expansion of epithelial stem cells |
05/30/2003 | CA2506616A1 Substituted bicyclo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients |
05/30/2003 | CA2467958A1 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna |
05/30/2003 | CA2467908A1 Mfg-e8-l regulates phagocytic removal of apoptotic cells by macrophages |
05/30/2003 | CA2467856A1 Anti-pathogenic composition useful in blood preservation |
05/30/2003 | CA2467819A1 Improvement of viability and function of pancreatic islets |
05/30/2003 | CA2467246A1 Composition and method for treatment of wounds |
05/30/2003 | CA2467223A1 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation |
05/30/2003 | CA2467195A1 Matrix for the production of tissue engineered ligaments, tendons and other tissue |
05/30/2003 | CA2466982A1 Pharmaceutical compositions in particulate form |
05/29/2003 | US20030101468 Unactivated oocytes as cytoplast recipients for nuclear transfer |
05/29/2003 | US20030100574 Tricyclic 3,4-propinoperhydropurines; uses thereof for blocking neuronal transmission |
05/29/2003 | US20030100526 Operably linked mammalian muscle creatine kinase promoter, mammalian desmin promoter and enhancers thereof, and vertebrate troponin I IRE enhancer; gene therapy |
05/29/2003 | US20030100513 Methods and compositions for increasing the anaerobic working capacity in tissues |
05/29/2003 | US20030100113 Plasmids for use in the transfer of nucleotide sequences into cells |
05/29/2003 | US20030100108 Matrix for the production of tissue engineered ligaments, tendons and other tissue |
05/29/2003 | US20030100107 Compositions and methods for generating differentiated human cells |
05/29/2003 | US20030099747 Thickened oil compositions of edible oil |
05/29/2003 | US20030099716 Botanical and non-botanical ingredients for symptomatic relief of sexually transmitted diseases and other urogenital disorders |
05/29/2003 | US20030099667 Virus modified by the insertion of cDNA of serotypes |
05/29/2003 | US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy |
05/29/2003 | US20030099643 Methods for selectively stimulating proliferation of t cells |
05/29/2003 | US20030099633 Methods and compositions for treatment of immune dysfunction disorders |
05/29/2003 | US20030099623 Isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression |
05/29/2003 | US20030099622 Administering a cell transplant from a donor to a recipient along with a mildly myeloablative conditioning treatment and an immune blockade treatment; prevents risk of profound neutropenia or graft-versus-host-disease (GVHD) |
05/29/2003 | US20030099621 Screening cells to identify stem cells having a beneficial gene, and transplanting the cells into a patient to treat HIV or AIDS |
05/29/2003 | US20030099620 Bonding two cartilage pieces with an adhesive material isolated chondrocytes in gels; implants for repairing bone defects |
05/29/2003 | US20030099619 Method and composition for targeting an adenoviral vector |
05/29/2003 | US20030099618 Administering a genetic engineered virus virions, comprising a nucleotide sequence able to code antihemophilic factor protein; patient's blood will able to clot |
05/29/2003 | US20030099611 Manipulation and detection of protein phosphatase 2c-pp2calpha - expression in tumor cells for cancer therapy, prevention and detection |
05/28/2003 | EP1314741A1 Bispecific anti-CD19 x anti-CD16 antibodies and uses thereof |
05/28/2003 | EP1314431A2 Newcastle disease virus for therapeutic use |
05/28/2003 | EP1314430A1 Treatment of non-neuronal cancer using HSV mutant |
05/28/2003 | EP1314429A2 Use of an antiretroviral compound to manufacture a medicament for the treatment of sjogren's syndrome, systematic lupus erythematosis, scleroderma, or juvenile rheumatoid arthritis |
05/28/2003 | EP1313864A2 Anti-microbial agents |
05/28/2003 | EP1313839A1 Immune potentiating compositions |
05/28/2003 | EP1313766A2 Coaster, a human coactivator of steroid receptors |
05/28/2003 | EP1313762A2 Suppressor gene |
05/28/2003 | EP1313753A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
05/28/2003 | EP1313574A1 Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |
05/28/2003 | EP1313512A1 Vascular endothelial growth factor 2 |
05/28/2003 | EP1313496A1 Use of a composition comprising an extract of pollen for the treatment of edema |
05/28/2003 | EP1313495A1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders |
05/28/2003 | EP1313494A1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
05/28/2003 | EP1313493A1 Use of a composition comprising an extract of pollen for the treatment of irritability |
05/28/2003 | EP1313492A1 Use of a composition comprising an extract of pollen for the treatment of dysphoria |
05/28/2003 | EP1243275A4 Insulin-containing medicament for peroral application and method for the production thereof |
05/28/2003 | EP1200112B1 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
05/28/2003 | EP1161251B1 Use of a composition comprising klebsiella pneumoniae proteoglycans, and bacterial ribosomes or ribosomal rna's for the preparation of a medicament for treating and/or preventing periodontal diseases |
05/28/2003 | EP1146885B1 Pre-conditioning against cell death |
05/28/2003 | EP1143983A4 Spray delivery of cells |
05/28/2003 | EP0918517B1 Composition of micro-organisms containing omega-3-fatty acid useful as a prophylactic or therapeutic agent against coccidiosis of animals |
05/28/2003 | EP0871457B1 Isolated stromal cells and methods of using the same |
05/28/2003 | EP0783314B1 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
05/28/2003 | CN1420936A Identification of cells for transplantation |
05/28/2003 | CN1420934A Targeted artificial gene delivery |
05/28/2003 | CN1420933A Method of inducing angiogenesis by micro-organs |
05/28/2003 | CN1420783A Compositions and methods for tumor-targeted delivery of effector molecules |
05/28/2003 | CN1420781A Bifidobacteria capable of preventing diarrhea |
05/28/2003 | CN1420770A Method of delivery of cetyl myristoleate |
05/28/2003 | CN1420759A Slimming composition contg. substance inducing IL-6 production |
05/28/2003 | CN1419929A Method for preparing Chinese medicine composition for treating tetanic rachitis complicated necrosis of femoral head |
05/28/2003 | CN1419928A Chinese medicine composition for treating tetanic rachitis complicated necrosis of femoral head |
05/28/2003 | CN1419927A Sieral schemes and Chinese medicine preparation for traditional Chinese medicine diagnosis and treatment of nephritis and nephropathy syndrome |
05/28/2003 | CN1419921A Chinese medicine capsule for treating diabetes |
05/28/2003 | CN1419915A External applied liquid medicine for treating psoriasis |
05/28/2003 | CN1109752C New strain of Bacillus licheniformis and its microecology preparation |
05/28/2003 | CN1109554C Medicine for treating allergic purpura |
05/28/2003 | CN1109553C Chinese medicine capsule for treating diabetes |
05/28/2003 | CN1109552C Enteritis curing capsule |
05/28/2003 | CN1109551C Medicine for treating cancer and process for preparing same |
05/28/2003 | CN1109549C Soft concentrated fish oil capsule and its supercritical CO2 extraction and rectification process |
05/28/2003 | CN1109548C Process for preparation of collagenous fibre tissue for animal's organs and blood vessels |
05/27/2003 | US6570002 Inhibitor of programmed cell death |
05/27/2003 | US6569838 Excising the keloid to create a wound, and administering bacterial polysaccharide exotoxin (cm101) to reduce scarring at a site of the wound |
05/27/2003 | US6569677 Viral genome mutations involving the recognition and binding of natural cell receptors for adenoviruses; use in human gene therapy applications |
05/27/2003 | US6569471 Administering water and/or fat-soluble cytosolic extract of pollen with Royal Jelly and Vitamin E to treat hormonal variations in fertile, peri- and post- menopausal women |
05/27/2003 | US6569467 Modifying extracted blood aliquot extracorporeally by subjecting it to an immune system-modifying amount of ozone gas and ultraviolet radiation; reinjecting the vaccine into the patient; rheumatoid arthritis, psoriasis |
05/27/2003 | US6569465 Collecting urine from a mammal, treating with an oxidizing agent in presence of oxygen in container, adding at least one protease, removing substances with a low molecular weight to yield a modified mammal urine |
05/27/2003 | US6569464 Antifertility agent comprises coelomic fluid extract which is obtained from an Indian earthworm, Pheretima posthuma, belonging to the phylum, Annelida |
05/27/2003 | US6569428 For regulating angiogenesis; nucleic acid encoding an endothelial cell mitogen and endothelial cell progenitors, where the EC progenitors are CD34+, Flk-1+, and tie-2+ |
05/27/2003 | US6569427 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
05/27/2003 | US6569424 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract |
05/27/2003 | US6569423 Regenerating nervous tissue by contacting tissue with an effective amount of Schwann cells expressing transcription factor Delta SCIP |
05/27/2003 | US6569416 Compositions containing synthetic soil-extract materials and medicaments based thereon |
05/27/2003 | US6569204 Bone tissue regenerating composition |
05/27/2003 | CA2158455C Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide and their uses in vaccines and disease treatments |
05/27/2003 | CA2131168C Decontaminating blood components |
05/22/2003 | WO2003042405A2 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |